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Abstract
Background: Dimeticones kill head lice by physical means. Here we assessed in a comparative
bioassay the ex vivo efficacy of "NYDA® sensitiv", a new two-phase dimeticone-based pediculicide
similar to a product established on the market, but without fragrances.
Methods: We compared efficacy of the new product to a positive dimeticone control group, a
sample of four other insecticidal and natural head lice products marketed in Germany, and an
untreated control. In a bioassay, lice were exposed ex vivo to products and examined for activity
for up to 24 hours, following a standard protocol.
Results: After 6 and 24 hours, 13.7 and 88.5% of untreated control lice did not show major vital
signs. In contrast, no lice showed major vital signs 5 minutes after treatment with the new product
or the control dimeticone group (NYDA®). This effect persisted at all observation points (100%
efficacy). Efficacy of 0.5% permethrin (Infectopedicul®) ranged between 76 and 96% in evaluations
between 5 min and 6 hours. All lice treated with a coconut-based compound (mosquito®
Läuseshampoo) did not show major vital signs after 5 min, but mortality was only 58% after one
hour. Pyrethrum extract (Goldgeist® forte) showed an efficacy of 22 - 52% between 5 min and 3
hours after treatment; after 6 hours, 76% of lice were judged dead. An oxyphthirine®-based
compound (Liberalice DUO LP-PRO®) killed 22 - 54% of lice in the first 6 hours.
Conclusions: The two-phase dimeticone compound NYDA® sensitiv is highly efficacious. The
removal of fragrances as compared to an established dimeticone product did not affect in vitro
efficacy.
Background
Head lice infestations are widespread and occur in all
socio-economic strata in low, middle and high-income
countries [1-3]. Anecdotal evidence suggests an increasing
prevalence of head lice in many countries. In addition, as
a result of the extensive use of neurotoxic insecticides,
Published: 14 December 2009
BMC Dermatology 2009, 9:12 doi:10.1186/1471-5945-9-12
Received: 20 July 2009
Accepted: 14 December 2009
This article is available from: http://www.biomedcentral.com/1471-5945/9/12
© 2009 Heukelbach et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Dermatology 2009, 9:12 http://www.biomedcentral.com/1471-5945/9/12
Page 2 of 6
(page number not for citation purposes)
such as permethrin and malathion, reports of resistances
to these pediculicides have increased in the recent years
[4-8].
However, many over-the-counter head lice products are
still not tested adequately for their efficacy - neither before
nor after licensing - and, unfortunately, lack efficacy. For
example, we recently reported that only one of six plant-
based head lice products marketed in Australia showed a
considerable degree of efficacy against adult head lice [9].
Thus, there is a clear need for standardized assessment of
alternative head lice treatments. In fact, there is now a
trend for a more evidence-based approach, and there have
been several promising reports of clinical trials and bio-
assays testing new topical head lice compounds [10-19].
The trends for product development in some countries
have changed from neurotoxic insecticides to products
containing substances acting by physical means [20].
These compounds, such as silicones, are of particular
interest for head lice control: they are considered non-
toxic to humans, and due to their mode of action develop-
ment of resistance is not expected [12,20-22]. The silicone
oil dimeticone coats the louse surface and enters the res-
piratory tract, thereby blocking spiracles and tracheae
[20,22]. Böckeler & Richling (2008) showed that a two-
phase product containing a mixture of two dimeticones of
different viscosity (NYDA®) was capable of entering the
tracheal system, subsequently asphyxiating lice [22]. We
have previously shown in a clinical trial and in an ex vivo
study that this two-phase dimeticone (marketed in Ger-
many, Austria, the UK, France, Denmark, Finland, Greece,
The Netherlands, Turkey and several other countries) is
highly efficacious against head lice [12,13]. Here we
report efficacy of a similar formulation, but without fra-
grances, and compare it to several other products.
Methods
The efficacy of "NYDA® sensitiv" was assessed in a bio-
assay, using adult head lice collected from heavily infested
individuals. We compared efficacy to a positive control
group, a sample of four other insecticidal and natural
head lice products on the German market, and an
untreated control group. The selection of products was
based on the aim of the study: to prove similar efficacy of
a new dimeticone formula, as compared to an established
two-phase dimeticone; and to compare these dimeticone
pediculicides with products based on other modes of
action (neurotoxic or plant-based), with a considerable
market share in Germany. Details of the six products
tested are depicted in Table 1.
The new product differs from the established dimeticone
product by the absence of fragrances. As a consequence,
concentrations of dimeticones are slightly changed. The
compound without fragrances contains a mixture of two
dimeticones of different viscosity, in a total concentration
of 92.4%, as compared to 92.0% in the product with fra-
grances. Fragrances used in NYDA® are α-terpineol and
Eucalyptus citriodora oil. The remaining difference in con-
centration between both dimeticone formulations was
substituted by middle-chain triglycerides, which is
another ingredient of both products.
Head lice used
Adult head lice (Pediculus capitis) were obtained by dry
combing with a fine toothed comb, from children living
in a community in the city of Fortaleza (northeast Brazil),
where head lice are endemic. Children had not treated
their infestations with topical compounds or taken any
antibiotics/antiparasitic drugs in the previous four weeks.
We examined lice for activity and physical integrity and
used fully active adult insects within 60 min after collec-
tion. Female and male lice were used.
Table 1: Details of products tested against head lice.
Ingredients Presentation Producer
NYDA® sensitiv 92% dimeticone, medium-chain triglycerides, 
jojoba wax
Solution in plastic bottle G. Pohl-Boskamp GmbH o KG, 
Hohenlockstedt (Germany)
NYDA® 92% dimeticone, medium-chain triglycerides, 
jojoba wax, fragrances
Solution in glass bottle G. Pohl-Boskamp GmbH o KG, 
Hohenlockstedt (Germany)
Liberalice DUO LP-PRO® Oxyphthirine® (triglycerides and lipid esters)* Lotion in plastic bottle Duhot S.A., Limal (Belgium)
Infectopedicul® 0.5% permethrin, ethanol (39 vol. %), 2-
propanol, purified water, propylene glycol, 
sodium dihydrogen phosphate
Solution in glass bottle InfectoPharm Arzneimittel und 
Consilium GmbH, Heppenheim 
(Germany)
Goldgeist® forte Pyrethrum extract (0,3%), piperonyl butoxide, 
chlorocresol, diethylene glycol
Solution in glass bottle Eduard Gerlach GmbH, Lübbecke 
(Germany)
mosquito® Läuseshampoo Soybean oil, coconut oil derivatives, purified 
water, sodium laureth sulphate, cocamidopropyl 
betaine, glycine soya, hydrolysed collagen, 
glycosphingolipids, geranium
Plastic bottle/shampoo Wepa Apothekenbedarf GmbH o. KG, 
Hillscheid (Germany)
* no further information available
Product names as marketed in Germany.BMC Dermatology 2009, 9:12 http://www.biomedcentral.com/1471-5945/9/12
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Pediculicidal bioassay
A previously published standardized method for ex vivo
assessment of efficacy of pediculicidal products was used
[9,13]: Lice attached to hair strands were immersed com-
pletely in undiluted products for 3 min and then placed
with hairs onto Whatman filter paper in 5 cm Petri dishes.
To prevent lice from desiccation, the filter paper was mois-
tened by 200 μl tap water. After placing lice on filter paper,
obvious pools of the products were wiped from the lice by
a jeweller's forceps directed under a dissecting micro-
scope. Lice were washed after 20 min by immersing the
strands into water for one minute. Hair strands and lice
were agitated using a jeweller's forceps, and then placed
on new Petri dishes with filter paper. Lice of the untreated
control group were washed after 20 min without any fur-
ther treatment.
The number of parasites tested was 50 in each treatment
and 131 in the control group. Lice were tested in batches
of nine to eleven insects, and results were then pooled.
The lice were examined for activity under a dissecting
microscope after 5, 10, 20, 30, 60, 120 and 180 min, as
well as after 6 hours. A final assessment was made after 24
hours - however, a high mortality in the control group was
expected, as lice desiccate without regular feeding.
Pre-defined criteria for evaluation of survival of lice were
used, based on activity, ataxic signs, ability to stay on hair,
as well as gut and leg movements. As the exact time point
of death of an insect is difficult to define, we defined strict
criteria for the determination of "mortality": Lice were
judged as "dead" if there were no vital signs or minor vital
signs present (merely internal gut movements, move-
ments of antennae, minimal leg movements with or with-
out stimulation by a forceps). Lice showing major vital
signs such as inability to walk in a progressive fashion or
no righting reflex when rolled onto the back - considered
as dead in many other bioassays [9] - were judged as alive.
A single observer performed all examinations to prevent
inter-observer variation. Due to differences in color and
odor of products, complete blinding was impossible. All
lice were maintained at 27-29°C and not fed during test-
ing.
Statistical analysis
Data were entered using Excel spreadsheets and checked
for entry-related errors. Binomial confidence intervals of
mortality rates were calculated using STATA® software ver-
sion 8.2 (Stata corporation, College Station, USA). The
significance of the difference of relative frequencies was
compared by applying Fisher's exact test.
Ethical aspects
The study was done in collaboration with local commu-
nity leaders and approved by the Ethical Review Board of
the Federal University of Ceará (Fortaleza, Brazil). Prior to
combing, study objectives were explained, and informed
written consent was obtained from children and their
guardians. All children and their families involved were
treated against head lice and other parasitic diseases with
oral ivermectin (Revectina®; 200 μg/kg body weight,
repeated after 10 days), or in the case of contra-indica-
tions, with a 1% permethrin-based lotion available over
the counter in Brazil (Kwell®). In Brazil, oral ivermectin is
registered for treatment of pediculosis and has been
shown to be effective against a variety of parasitic diseases
[23].
Results
Figure 1 details efficacies of the six tested products at dif-
ferent points in time, as compared to the untreated con-
trol group. All lice treated with both two-phase
dimeticones showed no major vital signs after 5 min, and
this effect persisted at all points in time (100% efficacy).
Efficacy of 0.5% permethrin (Infectopedicul®) ranged
between 76 and 96% in evaluations between 5 min and 6
hours. All lice treated with mosquito® did not show major
vital signs after 5 min, but recovered, and mortality was
only 58% after one hour. Goldgeist® forte showed an effi-
cacy of 22 - 52% between 5 min and three hours after
treatment. After six hours, 76% of lice were dead. How-
ever, in this group after 10 min 48%, and after 3 hours
36% of lice were fully active. Liberalice DUO LP-PRO®
killed 22 - 54% of lice in the first 6 hours. Independent of
the product applied, after 24 hours all lice were dead with
exception of lice treated with Liberalice DUO LP-PRO®
(92%, Figure 1).
In the untreated control group, all lice survived for up to
one hour. After six hours 13.7% of lice were dead, and
after 24 hours 88.5% (Figure 1).
The two-phase dimeticones performed significantly better
than Infectopedicul® at observations after 5 min (p =
0.003), 10 min (p < 0.001), 20 min (p = 0.006) and 2 h
(p = 0.001); better than mosquito® at observations after 20
min (p = 0.003), 30 min, 1 h, 2 h, 3 h and 6 h (all p <
0.001); and better than Liberalice DUO LP-PRO® and
Goldgeist® forte at all observations in the first six hours
after exposure to products (all p < 0.001). At other obser-
vation points, differences between products tested were
not statistically significant.
Discussion
Our data show that a new dimeticone-based head lice
product without fragrances is highly efficacious in a stand-
ardized pediculicidal bioassay. The removal of α-terpin-BMC Dermatology 2009, 9:12 http://www.biomedcentral.com/1471-5945/9/12
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eol and Eucalyptus citriodora did not affect efficacy, as
compared to the established two-phase dimeticone prod-
uct NYDA®.
Several recent studies have shown the efficacy of products
containing silicone oils. In clinical trials, preparations
based on silicones have shown a high efficacy as com-
pared to neurotoxic insecticides [11,12,14,24,25]. In a
recent comparative clinical trial, efficacy of two-phase
dimeticone was 97% after 9 days, as compared to 68%
efficacy of 1% permethrin [12]. Considering the similar ex
vivo efficacy of both two-phase dimeticones used in the
present study, it can be assumed that clinical efficacy of
the product without fragrances will be similar. In addi-
tion, an in vitro ovicidal assay has shown that the two-
phase dimeticone reveals almost 100% efficacy against
head lice eggs [26].
In a previous comparative bioassay we observed 100%
efficacy of NYDA® and 1% malathion (Prioderm®), com-
pared to 90% efficacy of 1% permethrin creme rinse
(Lyclear®) [13]. Lice treated with 4% dimeticone/96%
cyclomethicone (Hedrin®) showed a similar efficacy to
two-phase dimeticone in the first three hours after expo-
sure, but a considerable number of lice recovered after 6
hours [13].
In the present study, an alcoholic solution of 0.5% per-
methrin showed an efficacy ranging between 72 and 96%
in the first six hours after exposure. Similar results apply-
ing an identical methodology were found with permeth-
rin-based products from Australia, the UK and Brazil
[9,13,27]. The pyrethrum extract Goldgeist® forte showed
a low efficacy in our study.
Liberalice DUO LP-PRO® contains a compound called
oxyphthirine®, which is based on triglycerides and lipid
esters. Lice are claimed to be killed by asphyxiation, but
no adequate in vitro or clinical data are published con-
firming this assumption. In our assay, efficacy of this
product was low, indicating that a single topical applica-
tion, as recommended by the producer, is not sufficient to
eradicate lice. Resistance is an unlikely cause for the low
efficacy, as the assays were performed in Brazil where the
product is not commercialized yet and thus lice were most
likely naïve regarding exposure to oxyphthirine®.
A considerable number of lice exposed to the plant-based
product mosquito® recovered of sham death after some
time. Resistance may develop also against plant extracts,
but similar to permethrin we cannot conclude on resist-
ance patterns. In fact, death of insects is difficult to define,
and lice in particular have the ability to shut down their
metabolism and go into stasis; they may later recover
from an apparently morbid state [28,29]. Thus, in the
evaluation of head lice treatments, the end-point "death"
can only be determined by microscopy and by observing
the insects for a prolonged period, as done in our study.
Some authors have highlighted the need for an extended
observation period of at least 6 hours to confirm death
[13,27,28,30]. From the design of above cited studies and
data presented in this study, it cannot be concluded if
resistance is the cause for incomplete efficacy of pyre-
throids and plant products. This should be the focus of
future studies. Resistance of the Brazilian lice tested has
not yet been described.
Since our study was performed, another product (50%
isopropyl myristate, a fatty acid ester, and 50% cylcome-
Comparative efficacy (mortality) of head lice products at different points in time (n = 50 in test groups; n = 131 in control  group) Figure 1
Comparative efficacy (mortality) of head lice products at different points in time (n = 50 in test groups; n = 131 
in control group). Vertical bars indicate binomial 95% confidence intervals.BMC Dermatology 2009, 9:12 http://www.biomedcentral.com/1471-5945/9/12
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thicone) claimed killing lice by physical means has
entered the German market. Clinical trials have shown
efficacy of this compound [14,25].
Different house remedies such as application of mayon-
naise or olive oil have erroneously been reported to be
efficacious. In reality, these substances cause a transient
period of stasis, and lice usually are not observed during a
prolonged period. Interestingly, the majority of "resur-
rected" lice after exposure to mosquito® recovered from
"no vital signs" (data not shown).
Many in vitro studies used the inability to walk in a pro-
gressive fashion or loss of righting reflex when rolled over
as criteria for mortality [9]. We believe that the more strin-
gent criteria used in the present bioassay are adequate, if
lice are observed for a period of six hours or more. In fact,
mortality usually remains relatively constant after 3-6
hours of observation [13,27] and our study confirmed
this finding. Other authors used "no vital signs", includ-
ing complete cessation of gut peristalsis, as criterion for
mortality [9].
Even in control lice mortality increased considerably after
3 - 6 hours [13], owing to dehydration. A longer observa-
tion period would considerably bias efficacies of tested
products. Thus, we observed lice up to 6 hours with an
additional final assessment after 24 hours to assess mor-
tality in control group not exposed to pediculicides.
Clearly, the increased "efficacy" of some products after 6
hours of observation should be interpreted with caution,
due to increasing mortality in the control group.
Permethrin and malathion are generally considered safe,
when used correctly, but an increased awareness that neu-
rotoxical products may be harmful has been influencing
head lice therapy in the last years [20]. In some cases these
insecticides may cause adverse events such as skin irrita-
tion, paraesthesia, exacerbation of asthma and allergic
reactions. Incorrect use may cause more severe adverse
events. For example, a patient developed neck dystonia
for 24 hours after applying 5% permethrin and not wash-
ing for 10 hours [31]. One case control study found an OR
of 1.9 (95% CI: 1.1-3.3) for acute leukaemia in child-
hood, if insecticidal pediculicides were used in the past
[32]. Clearly, further studies are needed to prove causal
relationship of this association, but in general care should
be taken when using neurotoxic pediculicides. In coun-
tries where safe alternatives are available with efficacy
proven in well-designed studies, we recommend to avoid
the use of topical neurotoxic insecticides.
Conclusions
We have shown in a standardized bioassay that a two-
phase dimeticone product is a highly efficacious product
against head lice. The removal of fragrances as compared
to NYDA® did not affect efficacy. Permethrin showed a sat-
isfactory efficacy, but the majority of lice treated with
pyrethrum survived for a prolonged period. Highly con-
centrated dimeticone products can be seen as an alterna-
tive to neurotoxic pediculicides.
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